Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Author	dc.contributor.author	Prado Buzeta, Rodrigo
Admission date	dc.date.accessioned	2014-01-07T15:06:57Z
Available date	dc.date.available	2014-01-07T15:06:57Z
Publication date	dc.date.issued	2010-10-18
Cita de ítem	dc.identifier.citation	Lancet Oncol 2010; 11: 1048–56	en_US
Identifier	dc.identifier.other	DOI:10.1016/S1470- 2045(10)70230-8
Identifier	dc.identifier.uri	https://repositorio.uchile.cl/handle/2250/129099
General note	dc.description	Artículo de publicación ISI.	en_US
Abstract	dc.description.abstract	Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer.	en_US
Lenguage	dc.language.iso	es	en_US
Type of license	dc.rights	Attribution-NonCommercial-NoDerivs 3.0 Chile	*
Link to License	dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/cl/	*
Título	dc.title	Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study	en_US
Document type	dc.type	Artículo de revista

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile